Goldman Sachs initiated coverage on Silence Therapeutics (NASDAQ:SLN), currently trading at $4.92 with a market cap of $232.3 million, with a Sell rating and a price target of $6.00. According to ...

“Well left, The Man Who Must Remain Nameless and Faceless is a fast bowler and normally fast bowlers are tail Enders and when ...

AYANA Bali invites guests to experience the Sacred Silence of Bali, a period of complete silence to honour the Balinese New ...

Memorial Hospital and Health Care Center is excited to announce that the next recipient of the DAISY Award is Silence Tia Keller, FNP-C. Keller is a family nurse practitioner at Memorial Health ...

Radio Silence, the horror filmmaking banner known for reviving the Scream franchise, has signed with CAA. The banner was ...

Amazon and Warner Bros have put bid for a Radio Silence biopic about the late paranormal DJ Art Bell that would star Paul ...

Goldman Sachs initiated coverage of Silence Therapeutics (SLN) with a Sell rating and $6 price target The company is developing siRNA ...

Goldman Sachs analyst Richard Law initiated coverage of Silence Therapeutics (SLN) with a Sell rating and $6 price target Maximize Your ...